Sort
46,585 grants matching “heart failure”
Metabolic regulation of myocardial perfusion in the aging heart
$1,828,658Bradford Guy Hill · University Of Louisville · RF1 · FY2025 · AG
Mechanisms of Cardioprotection in Ischemia and Failure
$1,828,528Northern California Institute Res &Educ · P01 · FY2005 · HL
CLINICAL EXAMINATION CENTER
$1,828,181Aaron Folsom · University Of Minnesota · N01 · FY2015 · HL
CLINICAL EXAMINATION CENTER
$1,828,067Aaron Folsom · University Of Minnesota · N01 · FY2014 · HL
CABANA-AF Trial
$1,827,335Kerry L Lee · Duke University · U01 · FY2010 · HL
Novel Mechanisms and Therapies in Heart Failure
$1,826,364Howard A Rockman · Duke University · P01 · FY2011 · HL
Novel Mechanisms and Therapies in Heart Failure
$1,826,364Howard A Rockman · Duke University · P01 · FY2012 · HL
Vascular remodeling in patients with rare genetic disorders
$1,826,325Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease: 29-year Follow-Up of a Randomized Clinical Trial
$1,825,180David L Olds · University Of Colorado Denver · R01 · FY2022 · HL
Gene Therapy:Translating Basic Science to the Clinic
$1,825,063University Of California San Diego · P01 · FY2004 · HL
Center of Excellence in Gene Therapy(PROGRAM PROJECT)
$1,824,603Caritas St. Elizabeth'S Medical Center · P01 · FY2005 · HL
NATIONAL BIOMEDICAL COMPUTATION RESOURCE
$1,824,398Peter William Arzberger · University Of California, San Diego · P41 · FY2012 · GM
NHLBI iPSC Core Facility
$1,823,792Jizhong Zou · National Heart, Lung, And Blood Institute · ZIC · FY2019 · HL
Telemonitoring to improve heart failure outcomes
$1,823,141Yale University · R01 · FY2005 · HL
Biology and Novel Therapeutics of Cardiovascular Peptides
$1,822,223John C Burnett · Mayo Clinic Rochester · P01 · FY2013 · HL
TRANSFORM-HF CCC
$1,821,093Eric J Velazquez · Yale University · U01 · FY2019 · HL
EVALUATION OF HEART FAILURE AND PULMONARY ARTERY CATHETE
$1,820,496Duke University · N01 · FY2000 · HV
Serious Hazards of Transfusion & Cellular Therapies: Mechanisms and Interventio
$1,820,356John D Roback · Emory University · P01 · FY2012 · HL
Late-life trajectories of cardiac function to define pathways of cardiac resilience
$1,818,837Amil M Shah · Ut Southwestern Medical Center · R01 · FY2024 · HL
Biological mechanisms underlying the relationships between environmental exposures and risk of respiratory and cardiovascular diseases
$1,817,964Jason Wong · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Endothelium and Vascular Function
$1,816,877New York Medical College · P01 · FY2005 · HL
Trial to Assess Chelation Therapy (TACT)
$1,816,603Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach) · U01 · FY2012 · HL
Atherosclerosis Risk in Communities Study (ARIC)
$1,816,554Lloyd E Chambless · Univ Of North Carolina Chapel Hill · N01 · FY2010 · HL
Allogeneic Human Mesenchymal Stem Cells for the Treatment of Acute Lung Injury
$1,816,232Michael A. Matthay · University Of California, San Francisco · U01 · FY2015 · HL
Mechanisms of cardiovascular remodeling
$1,815,108University Of South Dakota · P20 · FY2005 · RR